ATTENTION: Law Offices of Samer Habbas & Associates is fully-operational during the COVID-19 global pandemic. We continue to handle cases and operate business as usual, in accordance with mandated safety guidelines.

X
Banner

Sleep deprivation causes over 100,000 car accidents and over 1,500 deaths per year, but that’s not to say sleeping aids are the answer to getting a good night’s sleep. Getting enough hours of sleep can save lives, but taking sleeping pills to prevent fewer car accidents is still risking a life… your own. Sleeping aids […]

On July 16, 2010, the Food and Drug Administration (FDA) decided to keep the diabetes drug Avandia (rosiglitazone) on the market despite a cardiovascular threat to some patients. Conflicting studies have shown that the drug rosiglitazone promotes increased cardiovascular risk to patients with diabetes. The FDA, as well as the Endocrine Society, the American Association […]

As part of our emphasis on client education, our California defective drugs attorneys would like you to know that while each defective drug and product liability case is unique, pharmaceutical product liability claims fall under three categories: Defectively manufactured drugs This type of claim includes people who have suffered an injury due to pharmaceuticals that […]

On the heels of a recall of one lot of their skin care product, pharmaceutical manufacturer Ranbaxy Pharmaceuticals, Inc. has also announced that they are voluntarily recalling two lots of the antibiotic drug from the U.S. market. Drug maker Ranbaxy recently recalled one lot of their 40 milligram Sotret Isotretinoin capsules, a drug that can […]

Drug maker Hospira, Inc. has issued a recall for two of its drugs for the second time in six months due to manufacturing defects. The U.S. Food and Drug Administration recently issued a warning about the defects, prompting the manufacturer to recall Propofol and Liposyn. Propofol, an anesthetic, and Liposyn, an intravenous nutritional product, were […]

Prescription drug manufacturer American Regent has issued a voluntary recall of every lot of their ketorolac tromethamine injection, 30 mg/ml product. The US Food and Drug Administration (FDA) announced recently that particulate matter and crystallization might be present in the drug that could result in obstruction of blood vessels. If a person injects the drug […]